Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised contr... by Gallwitz, Baptist, Prof, Guzman, Juan, MD, Dotta, Francesco, MD, Guerci, Bruno, MD, Simó, Rafael, MD, Basson, Bruce R, MSc, Festa, Andreas, MD, Kiljański, Jacek, MD, Sapin, Hélène, MSc, Trautmann, Michael, MD, Schernthaner, Guntram, Prof

Get full text